Evaluation of clinical harm associated with Omicron hospital-onset COVID-19 infection - 24/12/22
Doi : 10.1016/j.jinf.2022.10.029
Jonathan A. Otter a, b, ⁎ 
, William Newsholme a, Luke B. Snell a, Blair Merrick a, Nneoma Okeke a, Damien J.F. Mack c, Aodhán S Breathnach d, Nicholas M Price a
, William Newsholme a, Luke B. Snell a, Blair Merrick a, Nneoma Okeke a, Damien J.F. Mack c, Aodhán S Breathnach d, Nicholas M Price a a Directorate of Infection, Guy's and St. Thomas NHS Foundation Trust, St. Thomas’ Hospital, Lambeth Palace Road, London, SE1 7EH, United Kingdom
b National Institute for Healthcare Research Health Protection Research Unit (NIHR HPRU) in HCAI and AMR, Imperial College London & Public Health England, Hammersmith Hospital, Du Cane Road, W12 0HS, United Kingdom
c Department of Microbiology, Royal Free Hospital, Royal Free London NHS Foundation Trust, Pond Street NW3 2QG, United Kingdom
d Department of Infection, St George's University Hospitals NHS Foundation Trust, Tooting, London SW17 0QT, United Kingdom
⁎Corresponding author at: Directorate of Infection, St. Thomas’ Hospital, Lambeth Palace Road, London, SE1 7EH, United Kingdom.Directorate of InfectionSt. Thomas’ Hospital, Lambeth Palace RoadLondonSE1 7EHUnited Kingdom
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Highlights |
• | We reviewed outcomes for 129 patients with Omicron hospital-onset COVID-19 infection. |
• | 86 (66.7%) were asymptomatic; 15 (11.6%) had increased length of stay. |
• | 11 (8.5%) required supplemental oxygen, two (1.6%) required ICU or HDU. |
• | 3 (2.3%) had COVID-19 as a direct cause of death, and 4 (3.1%) where COVID-19 contributed. |
• | No associations between harm and age, vaccination, or vulnerability were found. |
© 2022
The British Infection Association. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 86 - N° 1
P. 66-117 - janvier 2023 Retour au numéro
Article précédent
- Regdanvimab improves disease mortality and morbidity in patients with COVID-19: Too optimistic and too early to say?
- Robert Marcec, Vinko Michael Dodig, Robert Likic
- Red herrings in monkeypox
- Marco Bongiovanni, Daniele Piccinini, Fabian Joel Aschwanden, Enos Bernasconi
Bienvenue sur EM-consulte, la référence des professionnels de santé.